Examining how economic policies affect the use of HIV prevention medication in the U.S.
Assessing the Impact of Economic Policies on the Use of Pre-Exposure Prophylaxis in the United States
This study looks at how new economic policies affect the use of PrEP, a medication that helps prevent HIV, among men who have sex with men in the U.S., and it aims to find ways to improve public health and reduce HIV transmission.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pennsylvania NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-10893030 on NIH RePORTER |
What this research studies
This research investigates the impact of recent economic policies on the use of pre-exposure prophylaxis (PrEP) among men who have sex with men (MSM) in the United States. It employs a multi-level, longitudinal analysis that integrates prescription data, surveys, and consumer data to understand how these policies influence PrEP uptake and persistence. The study aims to identify effective public health policies that can help achieve the goals of ending the HIV epidemic by examining the relationship between these policies and behavioral factors such as attitudes and norms. By modeling the effects on HIV transmission, the research seeks to provide insights into improving health outcomes for at-risk populations.
Who could benefit from this research
Good fit: Ideal candidates for this research include men who have sex with men, particularly those who are Black, Hispanic, or White, and who may benefit from increased access to PrEP.
Not a fit: Patients who are not at risk for HIV or who do not engage in behaviors that would necessitate PrEP may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved access to HIV prevention methods for high-risk populations, ultimately reducing HIV transmission rates.
How similar studies have performed: Other research has shown success in understanding the impact of public health policies on medication uptake, suggesting that this approach could yield valuable insights.
Where this research is happening
Philadelphia, United States
- University of Pennsylvania — Philadelphia, United States (Active)
Researchers
- Principal investigator: Fayaz Farkhad, Bita — University of Pennsylvania
- Study coordinator: Fayaz Farkhad, Bita
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.